N,N-Bis(2-hydroxyethyl)decanamide,
Capramide DEA,
136-26-5,
Upamide CD,
Capric diethanolamide,
DECANAMIDE, N,N-BIS(2-HYDROXYETHYL)-,
N,N-Bis(2-hydroxyethyl)decan-1-amide,
Capric acid diethanolamide,
UNII-SHH19DQ1DH,
EINECS 205-234-9,
SHH19DQ1DH,
BRN 1785093,
Standamid CD,
Amidex CP,
Monamid 150-CW,
1:1 Capramide DEA,
C9DEA,
AC1L1UHR,
3-04-00-00706 (Beilstein Handbook Reference),
Bis(2-hydroxyethyl)decanamide,
SCHEMBL354621,
DTXSID3042184,
CTK4H8021,
N,N-bis-{hydroxyethyl}decanamide,
BPXGKRUSMCVZAF-UHFFFAOYSA-N,
n,n-bis(2-hydroxyethyl)caprinamide,
n,n-bis(2-hydroxyethyl)capric amide,
ZINC95811693,
AKOS010484676,
AN-23112,
LS-59262,
EN300-80114,
UNII-92005F972D component BPXGKRUSMCVZAF-UHFFFAOYSA-N,
37345-28-1,
Hega-10,
C14H29NO3,
CID61081,
C14-H29-N-O3,
N, N- bis(2- hydroxyethyl)decan- 1- amide,
2CV,